Technological advancements have significantly enhanced hit validation in cancer research. High-throughput screening technologies, computational modeling, and artificial intelligence (AI) are now integral parts of the process. These technologies enable researchers to analyze large datasets, predict potential off-target effects, and design more effective validation experiments.
